IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
1,557,666
1,557,666
1,542,448
1,371,868
1,517,557
Cost of Revenue
587,355
587,355
597,808
520,834
564,681
Gross Profit
970,311
970,311
944,640
851,034
952,876
Operating Expenses
Research Development
101,193
101,193
93,051
77,381
79,573
Selling General and Administrative
616,316
616,316
637,445
594,526
687,599
Total Operating Expenses
731,391
731,391
747,410
699,664
794,200
Operating Income or Loss
238,920
238,920
197,230
151,370
158,676
Interest Expense
49,594
49,594
50,395
71,581
53,957
Total Other Income/Expenses Net
12,651
12,651
61,105
4,434
-55,394
Income Before Tax
213,894
213,894
214,677
93,520
60,104
Income Tax Expense
33,344
33,344
45,602
-40,372
9,903
Income from Continuing Operations
180,550
180,550
169,075
133,892
50,201
Net Income
180,550
180,550
169,075
133,892
50,201
Net Income available to common shareholders
180,550
180,550
169,075
133,892
50,201
Basic EPS
-
2.18
2.00
1.59
0.59
Diluted EPS
-
2.16
1.98
1.57
0.58
Basic Average Shares
-
82,997
84,698
84,337
85,637
Diluted Average Shares
-
83,516
85,485
85,228
86,494
EBITDA
-
277,370
281,986
192,858
141,089